دورية أكاديمية

2212MO Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?

التفاصيل البيبلوغرافية
العنوان: 2212MO Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?
المؤلفون: Hackshaw, A., Newbold, K., Beasley, M., Garcez, K., Wadsley, J., Johnson, S., Stephenson, T., Gaze, M.N., Goodman, A., Jeffries, S., Wilkinson, D., Macias, E., Power, D., Roques, T., Speed, L., Gerrard, G., Forsyth, S., Chang, E., Farnell, K., Mallick, U.K.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S1142-S1142
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.994